DIR Return Create A Forum - Home
---------------------------------------------------------
Renewable Revolution
HTML https://renewablerevolution.createaforum.com
---------------------------------------------------------
*****************************************************
DIR Return to: Advances in Health Care
*****************************************************
#Post#: 8505--------------------------------------------------
Re: Cancer
By: AGelbert Date: December 2, 2017, 3:21 pm
---------------------------------------------------------
Agelbert NOTE: Did you know that ALL cancer cells (from ALL
types of cancers) have mitichondrial dysfunction? Healthy
mitochondria are the ultimate cancer cell suppressors. The
importance of that fact for your health goes beyond cancer
prevention to metabolic disease prevention and/or therapy.
[center][font=times new roman]How Metabolic Therapies Prevent
and Treat Chronic Diseases[/font][/center]
December 02, 2017 • 116,071 views
[center]
HTML https://youtu.be/gONeCxtyH18[/center]
[color=navy]Story at-a-glance[/color]
[quote]֍ Mounting evidence shows conditions such as
Alzheimer’s and cancer are metabolic diseases, which means you
can prevent, treat and recover from them like other metabolic
conditions, such as Type 2 diabetes and heart disease
[color=green][size=14pt]֍ A number of experts and
researchers are now convinced the answer to our burgeoning
cancer and Alzheimer’s epidemics is a ketogenic diet and other
metabolic support, such as fasting, hyperbaric oxygen treatment
and dietary supplementation
֍ During fasting or ketosis, your brain switches to using
ketone bodies derived from dietary fats as its primary fuel, and
ketones have potent neuroprotective effects and enhance brain
function
֍ Healthy cells have the metabolic flexibility to use
either glucose or ketones (obtained through your diet from
carbohydrates and healthy fats respectively), whereas cancer
cells cannot use ketones for fuel due to having damaged
mitochondria
֍ Nutritional ketosis prevents and combats cancer by
optimizing mitochondrial function, decreasing blood glucose and
insulin, increasing tissue oxygenation, decreasing free radical
generation, downregulating oncogenes and upregulating tumor
suppressor genes[/size][/color][/quote]
Detailed article with more video: [img width=75
height=50]
HTML http://www.pic4ever.com/images/reading.gif[/img]
HTML https://articles.mercola.com/sites/articles/archive/2017/12/02/metabolic-therapy.aspx
#Post#: 8506--------------------------------------------------
Re: Cancer
By: AGelbert Date: December 2, 2017, 3:48 pm
---------------------------------------------------------
[quote author=Eddie link=topic=559.msg141824#msg141824
date=1512246930]
[quote author=agelbert link=topic=559.msg141821#msg141821
date=1512236240]
[center]The Tax Scam[img
width=150]
HTML http://renewablerevolution.createaforum.com/gallery/renewablerevolution/3-270117175421.png[/img]<br
/>Passed the Senate. What Now?[/center]
December 2, 2017
Republicans have jammed the Trump Tax Scam through the Senate,
by a vote of 51-49. It’s hard to imagine how this bill could be
worse: not only does it give massive tax cuts to the rich and
corporations, it also allows drilling in the Arctic National
Wildlife Reserve, exacerbates growing inequality, and adds $1
trillion to the deficit—which will force deep cuts to Medicaid,
Medicare, and Social Security down the road.
The Tax Scam is not yet law. Republicans have two options for
how to get the Tax Scam across the finish line, and then they
have to immediately attend to funding the government. Here’s
what comes next.
OPTION A: “GO TO CONFERENCE”
Since the House and Senate passed different versions of the Tax
Scam, one option for Republicans is to merge them together by
“going to conference.” This is where members of the House and
Senate are appointed to a conference committee. The goal is to
work out the differences between the bills and put them together
into one “conference report” which is then voted on by both the
House and Senate.
There are a number of important differences between the two
bills, first and foremost the repeal of the individual mandate
that was included in the Senate version but not the House. There
are also differences between the individual tax rates, the
estate tax, and the alternative minimum tax.
Republicans have all publicly ;) said they want to go to
conference. Going to conference would more closely resemble
“regular order” and allow for some review of what is in these
bills. That extends the process of passing the Tax Scam by at
least two weeks or so, because they have to appoint conferees,
come up with the agreement, and then vote on it in both
chambers. Given the deep unpopularity of the Tax Scam, it’s
likely they’ll try to avoid conference at any cost by instead
choosing Option B…
OPTION B: THE HOUSE PASSES THE SENATE BILL—AS IS
To really put the pedal to the metal on finishing the Tax Scam,
Republicans can instead have the House pass the version just
passed by the Senate. Even though Republicans have all said they
want to go to conference, it would save them a ton of time and
trouble to go this route instead. If the votes are there in the
House to pass the Senate bill, they will.
Look for Speaker Ryan to quietly spend the weekend twisting arms
behind the scenes. There is currently a vote scheduled on
Monday, December 4 to “instruct conferees” (tell the members of
the Conference Committee what to do)—but this could easily be
turned into a vote on the Senate bill itself if the votes are
there.
[center]TURNING TO GOVERNMENT FUNDING AND DREAM[/center]
If Republicans go with Option A, it will mean the conference
report on the Tax Scam takes a back seat to next week’s main
event: finding a way to fund the government by the December 8
deadline. If they go with Option B, and the bill passes the
House, it will mean Congress has finished its work on the Tax
Scam.
Either way, our attention now needs to be on funding the
government and holding Democrats to their commitment to secure
inclusion of the DREAM Act in the funding bill. Democrats have
promised for three months that they will use their leverage on
the December spending bill to get the DREAM Act done. Now it’s
time for them to deliver. Read more and find out how you can
help Dreamers at www.dreamerpledge.org
HTML http://www.dreamerpledge.org
.
HTML https://www.trumptaxscam.org/what-now
HTML https://www.trumptaxscam.org/what-now
[/quote]
Nothing in this tax plan benefits anyone as far down the food
chain as I am. I noticed that (as usual) that doctors and
lawyers are explicitly denied the corporate tax loopholes, as
has been the case for decades now. Bend over, citizens.
[/quote]
Yep. :(
Thank you for this info. People need to know that even a
professional like you with a degree in medicine is not going to
benefit in comparison with the elite crooks this Tax Scam was
pushed through for.
By the way, if you have the time, check out the video and the
article I just posted. There is some fascinating new info on
metabolic activity. For example, you and I were taught that the
brain gets energy exclusively from glucose metabolism. It turns
out that is not true. Ketone metabolism has been found to
inhibit all sorts of deleterious activity like siezures and
ischemic conditions. It's really strange because it turns out
too much oxygen (study of U.S. Navy divers) caused seizures and
ALSO anoxic condition ischemia and metabolic disease conditions
can both be treated with ketone therapy. It's a bit involved for
the average joe but you have all the years of study to
understand this. It seems like a great avenue for improved
health. If you find any flaws that they don't mention (e.g.
ketosis downsides for our health), please fill me in.
#Post#: 11102--------------------------------------------------
Re: Cancer
By: AGelbert Date: November 13, 2018, 12:30 pm
---------------------------------------------------------
[font=courier]CANCER TODAY[/font]
Practical Knowledge. Real Hope.
from the American Association for Cancer Research
September 25, 2018
[center]New Tactics for Bladder Cancer[/center]
[center]
After decades without treatment advances, options for patients
with bladder cancer are now more numerous. 👍 [/center]
by Kendall K. Morgan
WHEN KARL PRITCHARD noticed blood in his urine one morning in
February 2014, he made an appointment with his primary care
d​octor. The doctor told Pritchard, who was 76 years old
at the time, that if he didn’t have a bladder infection, the
blood was probably a sign of cancer.
When a course of antibiotics didn’t resolve the issue, the
doctor ordered a CT scan and had his office schedule an
appointment with a urologist near Pritchard’s home in Edenton,
North Carolina. The urologist performed a cystoscopy, threading
a small tube with a light and lens through the urethra and into
the bladder, which revealed a tumor. The specialist surgically
removed a sample of tumor tissue that included the inner wall of
the bladder and its underlying muscle. The biopsy results and CT
scan indicated the cancer was boring its way into the muscle
layer of the bladder wall. [img
width=30]
HTML http://www.createaforum.com/gallery/renewablerevolution/3-300714025456.bmp[/img]<br
/>
...
[center][img
width=600]
HTML https://www.cancertodaymag.org/PublishingImages/issues/2018%20Fall/14.2-new-tactics-for-bladder-cancer-600.jpg[/img][/center]
Bladder cancer survivor Karl Pritchard enrolled in a clinical
trial for a PD-L1 inhibitor prior to its approval by the U.S.
Food and Drug Administration for treating bladder cancer. He
currently has no evidence of disease. Photo by Ed Cunicelli, ©
2016 Cancer Support Community
Within weeks, Pritchard had robotic surgery to remove his
bladder. After pathology reports came back, he was diagnosed
with stage III urothelial carcinoma. Urothelial cancer is the
most common type of bladder cancer in the U.S., and the standard
treatment for Pritchard’s type of cancer includes surgery and
the chemotherapy drug cisplatin. However, during Pritchard’s
operation, the surgeon discovered the tumor had damaged his left
kidney by blocking blood flow to the ureter, a duct that
transports urine from the kidney to the bladder. His right
kidney was also damaged due to a complication from surgery.
The compromised kidney function made Pritchard ineligible for
chemotherapy, which for decades had been the only drug option
approved by the U.S. Food and Drug Administration (FDA) for
invasive bladder cancer. The kidneys are essential for ridding
the body of waste products, including chemotherapy drugs. While
the treatment might have helped keep the cancer at bay, it would
have almost certainly done further damage to the kidneys. It
wasn’t worth the risk.
At the time, “the only thing I knew about cancer was how to
spell it,” Pritchard says. He resolved to pore over everything
he could find about bladder cancer. In an internet search, he
stumbled across what sounded like a promising experimental
option: immunotherapy drugs known as checkpoint inhibitors.
Immunotherapy treatments enlist the immune system in the fight
against cancer. In 2011, the checkpoint inhibitor Yervoy
(ipilimumab), which inhibits a protein known as CTLA-4, was
approved to treat patients with metastatic melanoma. In the same
year that Pritchard received his diagnosis, two immunotherapy
treatments, which are part of a class of drugs known as PD-1 and
PD-L1 inhibitors, received FDA approval for metastatic melanoma.
PD-1 is found at the surface of immune cells, and PD-L1 can be
found in abundance in some types of cancer. When these two
proteins bind, the immune cells are unable to attack the cancer
cells. By blocking either PD-1 or PD-L1 and thereby preventing
the interaction between them, this class of checkpoint inhibitor
releases the “brakes” on the immune system, allowing the body to
go full throttle against cancer.
But these drugs were years away from approval for treating
bladder cancer when Pritchard asked in May 2014, soon after his
operation, whether immunotherapy might be an option for him. His
surgeon responded that he should get his affairs in order.
Despite the surgical removal of Pritchard’s bladder, a PET scan
later showed cancer in his pelvis and lymph nodes in his
abdomen, glowing “like headlights in a dark room,” Pritchard
says. [img
width=30]
HTML http://www.createaforum.com/gallery/renewablerevolution/3-150715183719.png[/img]
Overcoming the Odds
In the U.S., about 80,000 people will receive a diagnosis of
bladder cancer this year, and more than 700,000 people are now
living with the disease. About 75 percent of people diagnosed
with bladder cancer live at least five years after their
diagnosis. That’s because most bladder cancers are caught in the
early stages, when the cancer is only in the inner lining of the
bladder. Once the cancer invades the surrounding deep muscle or
spreads to nearby lymph nodes, the patient’s chances of survival
drop precipitously. Pritchard’s inability to undergo treatment
left him in an even more tenuous position.
Despite the long odds, Pritchard [img
width=30]
HTML http://www.createaforum.com/gallery/renewablerevolution/3-210614221847.gif[/img]<br
/>wasn’t ready to give up. He asked his oncologist the same
question he had asked the surgeon: What about immunotherapy? As
luck would have it, his oncologist’s office was affiliated with
another office based in Norfolk, Virginia, that was recruiting
patients for a clinical trial to analyze a checkpoint inhibitor
called Tecentriq (atezolizumab) for advanced bladder cancer.
Pritchard visited the Norfolk office and had a sample of his
previously frozen bladder tissue sent off for analysis for the
study. Because his tumor expressed high levels of PD-L1 and he
was not a candidate for chemotherapy, he was eligible to enroll
in the trial.
HTML http://renewablerevolution.createaforum.com/gallery/renewablerevolution/1/3-111018132400-16842321.gif<br
/>
He received his first infusion of Tecentriq in February 2015,
joining the study along with 118 other patients with locally
advanced or metastatic bladder cancer for whom chemotherapy
wasn’t an option. He began receiving infusions of the drug every
three weeks at the Norfolk clinic, 70 miles from his home.
Scans, taken every other month, first showed the tumors
shrinking dramatically and then indicated no evidence of cancer.
HTML http://renewablerevolution.createaforum.com/gallery/renewablerevolution/1/3-120818185039-1655102.gif
Pritchard was fortunate. The study results from the trial arm he
participated in showed that just about 20 percent of patients
with otherwise untreatable bladder tumors responded to the
immunotherapy treatment. About 25 percent of patients whose
tumors had high levels of PD-L1 expression responded. In May
2016, the FDA approved Tecentriq to treat advanced or metastatic
urothelial carcinoma that hasn't responded to platinum-based
chemotherapy, making it the first PD-1 or PD-L1 inhibitor
approved to treat the disease. In April 2017, the FDA extended
the drug’s approval as a first-line treatment for people with
locally advanced or metastatic urothelial carcinoma who aren’t
eligible for treatment with cisplatin.
The FDA has now approved four additional checkpoint inhibitors
for bladder cancer: Bavencio (avelumab), Imfinzi (durvalumab),
Keytruda (pembrolizumab) and Opdivo (nivolumab). Surgery and
chemotherapy are still considered the standard of care for
bladder cancer. However, patients on chemotherapy whose cancer
progresses or who, like Pritchard, are unable to receive
chemotherapy for other reasons now have viable treatment
alternatives. ​​
Detecting Bladder Cancer
Researchers explore using urine tests to monitor patients for
signs of recurrence.
​Research on the Rise
The number of clinical trials in bladder cancer has grown since
the time of Pritchard’s diagnosis in 2014. For example, a recent
search using ClinicalTrials.gov, an online repository of
research trials, shows more than 260 studies are enrolling
patients with bladder cancer.
Researchers are exploring the use of combinations of
immunotherapies or immunotherapy plus chemotherapy. For
instance, a team led by researchers at the Icahn School of
Medicine at Mount Sinai in New York City recently reported the
results of a phase II clinical trial showing that metastatic
bladder cancer patients, especially those whose tumors carry DNA
repair defects, may benefit from receiving the chemotherapy
drugs gemcitabine and cisplatin together with Yervoy. A phase II
tr​ial set to begin in September 2018 is analyzing this
chemotherapy combination plus Opdivo in patients with
muscle-invasive bladder cancer.
There is also interest in combining existing checkpoint
inhibitors with IDO inhibitors, which target other proteins
shown to help cancer escape the immune system. (Of note,
however, a phase III clinical trial testing​ this
combination approach in melanoma recently ended in failure.) In
March 2018, the FDA granted breakthrough therapy designation to
a drug called enfortumab vedotin, which means the agency is
expediting its development and review, for use in patients with
locally advanced or metastatic bladder cancer who have
previously received checkpoint inhibitors. The treatment, while
not an immunotherapy, targets a protein called nectin-4 that’s
highly expressed in most metastatic bladder cancers. One study
found that about 50 percent of patients with metastatic
urothelial carcinoma responded to the treatment.
Researchers are also looking into combining chemotherapy with
drugs targeting a blood vessel growth factor called VEGF. In
addition, a phase II​​ clinical​ trial
recently showed that about 40 percent of patients whose
metastatic urothelial cancers carry mutations in the FGFR3 gene
respond to treatment with an oral drug called erdafitinib, which
also received the FDA’s breakthrough therapy designation for
metastatic bladder cancer in March 2018. The drug targets all
FGFR proteins, including the mutated FGFR3 found in as much as
20 percent of metastatic bladder cancers. Researchers are also
exploring whether epigenetic drugs, some of which can chemically
alter the surface of DNA to influence gene expression, might
reinvigorate a response to immunotherapy after it stops working.
“As a urologist who has been involved in clinical trial research
for the last 20 years, it’s been very rewarding to see in the
last two to three years, and certainly now, a renewed awakening
in the bladder cancer clinical trials landscape,” says Neal
Shore, a urologic oncologist and director of the Carolina
Urologic Research Center in Myrtle Beach, South Carolina. “For
almost three decades, we didn’t have a lot to be excited about,
and now we have a lot of really interesting clinical trials with
different molecules targeting different molecular pathways.”
Matching Treatments to Patients
With all the emerging choices, researchers also are focusing on
finding biomarkers to couple the most promising treatment option
with a patient’s unique tumor genetics. With a better
understanding of how specific markers make the cancer behave,
“you could not only detect the cancer, but pinpoint how to treat
it,” says David McConkey, a research scientist and director of
the Johns Hopkins Greenberg Bladder Cancer Institute in
Baltimore. “My vision is that some patients will be assigned
pre-surgical chemotherapy and some pre-surgical
immunotherapy—maybe some will be assigned to receive both at
same time,” McConkey says.
The Cancer Genome Atlas, a comprehensive project by the National
Cancer Institute to categorize the DNA changes in various cancer
types, recently analyzed tissue samples of more than 400
muscle-invasive bladder tumors, McConkey notes. This research
has uncovered 58 significantly mutated genes and five distinct
molecular subtypes of bladder cancer, which could aid in pairing
treatments with the genetics of a patient’s tumor. But there’s
more work to be done.
“In the future, we’re going to have to learn about the biology
of a tumor and make decisions based on that biology, and
everybody will be different,” says Matthew Milowsky, a urologic
oncologist at the University of North Carolina at Chapel Hill.
Milowsky is leading a study sponsored by the Bladder Cancer
Advocacy Network that provides free genomic testing to patients
with metastatic bladder cancer to help identify the most
promising clinical trials and to develop a tissue repository for
future research.
In many cases, this kind of molecular characterization is
already guiding treatment choices for patients with bladder
cancer, but it’s not being used everywhere, Milowsky cautions.
An important question will be “how do we translate such efforts”
to reach more people, the majority of whom receive care in
community health care settings.
Fortunately, Pritchard asked about immunotherapy and found a
path to a clinical trial that would ultimately extend his life.
He still goes in for regular blood draws and infusions of
Tecentriq every three weeks as part of the ongoing clinical
trial. There is no evidence of cancer in his body, but he
continues to search the web daily to learn about new treatments.
And even though Pritchard is unable to lift more than 25 pounds
because of his surgery and he tires easily—a common side effect
of immunotherapy treatment—he says his quality of life is “still
very good.”​
For others who find themselves in a similar position, he has
some advice: “Doctors see so many patients each day and can’t
remember all the details. As a patient, you need to speak up for
yourself.” Ask questions, he says, and, if you aren’t satisfied
with the response, keep asking until you are. ​[img
width=40]
HTML http://renewablerevolution.createaforum.com/gallery/renewablerevolution/3-130418202709.png[/img]<br
/>
HTML https://www.cancertodaymag.org/Pages/Fall2018/New-Tactics-for-Bladder-Cancer.aspx
#Post#: 16841--------------------------------------------------
Medical Boards Silencing Good Doctors
By: AGelbert Date: August 17, 2021, 11:53 am
---------------------------------------------------------
June 20, 2019
[center]Medical apartheid: how state medical licensing boards
are silencing good doctors using effective,non-toxic therapies
[img
width=35]
HTML http://renewablerevolution.createaforum.com/gallery/renewablerevolution/3-130418200018.png[/img][/center]
About the authors:
Richard Gale ✨is the Executive Producer of the
Progressive Radio Network and a former Senior Research Analyst
in the biotechnology and genomic industries.
Dr. Gary Null ✨ is the host of the nation’s longest
running public radio program on alternative and nutritional
health and a multi-award-winning documentary film director,
including The War on Health, Poverty Inc and Silent Epidemic.
SNIPPETS:
Those who are responsible for this medical genocide are never
held accountable. In fact, they are rewarded.
This presents a double standard because these are the same
leaders of the modern medical regime who most viciously attack
safer natural protocols. They make every effort to contain
alternative medicine, which they perceive as a threat to their
control over the nation’s healthcare.
We have discovered a term that describes this phenomenon well:
Medical Apartheid. ... ...
Consequently, the apartheid regime acts as a court that both
charges and convicts without a jury. It plays the role of judge
and executioner. And this apartheid is now being demonstrated
everywhere.
An excellent example is the career of Dr. Linus Pauling ✨
[img
width=40]
HTML http://renewablerevolution.createaforum.com/gallery/renewablerevolution/1/3-120818185037-16412296.gif[/img],<br
/>one of the most prolific medical researchers in American
history. Pauling had a distinguished career at Cal Tech
University for over three decades, published over 1,200
scientific papers and books, and was the rare recipient of the
Nobel Prize on two separate occasions.
Yet despite his spectacular career, it was his discovery that
large doses of Vitamin C could prevent and reduce the severity
of colds and flu infections that turned him into a pariah within
the medical establishment. His later discovery that mega-doses
of Vitamin C could be used to treat terminal cancer further
labeled him as a dangerous heretic.
During a private conversation with Dr. Pauling, he shared with
me his personal disappointment with the conventional medical
community and predicted that in the future his entire career
would be reduced to having been an advocate of pseudoscience.
Indeed, his prophecy was fulfilled. Wikipedia describes
Orthomolecular Medicine, a modality of alternative medicine
co-founded by Drs. Pauling and Abram Hoffer, which is based upon
maintaining optimal health with nutritional supplementation, as
“food faddism” and “quackery.”
And despite the tens of thousands of peer-reviewed studies
showing a wide range of health benefits for hundreds of
different nutrients, Wikipedia only presents several dismal and
poor quality studies that claim the opposite.
Dr. Pauling’s case is a lesson to better understand why
thousands of medical doctors and followers of non-conventional
protocols are fearful that their work to heal patients may
actually destroy their careers and reputations.
And this identifies a tactic of the Medical Apartheid: frame
alternative medical practitioners and their advocates as enemies
of public health and detain them in a prison of anxiety, so they
are fearful to reach out beyond the barbed walls of their gulag.
Full article: [img
width=40]
HTML http://renewablerevolution.createaforum.com/gallery/renewablerevolution/3-130418200416.png[/img]<br
/>
HTML https://www.nexusnewsfeed.com/article/human-rights/medical-apartheid-how-state-medical-licensing-boards-are-silencing-good-doctors-using-effective-non-toxic-therapies/
[img
width=100]
HTML http://renewablerevolution.createaforum.com/gallery/renewablerevolution/3-191017143841.jpeg[/img]<br
/>Agelbert NOTE: For those who have difficulty believing the
extent to which the medical community has been corrupted or
coerced and compromised, the following (thoroughly informative
[img
width=20]
HTML http://renewablerevolution.createaforum.com/gallery/renewablerevolution/3-250817121424.gif[/img])<br
/>answer to a question posed by a worried Cancer Patient may
interest you:
[center]I am newly diagnosed with colon cancer. How do I move
forward mentally and emotionally? [img
width=50]
HTML http://www.createaforum.com/gallery/renewablerevolution/3-150715183719.png[/img][/center]
Answer by Ian Clements 👍 Updated July 11, 2020
As someone who was diagnosed with terminal cancer and only given
weeks to live, and then went to three :o more oncologists (who
confirmed the initial prognosis), and went into trauma, I feel
for you.
We all have to do our own thing, but for me being a strongly
pro-active and assertive person, I just kept going looking for a
‘solution’. This involved initially getting and following the
advice of a nutritionist who promised that if I followed his
protocol I’d be cured - I did, exactly; for three months. The
tumour that had been removed returned big-time; I went into
severe decline; and into a hospice to die.
Whilst on the protocol (which did, I believe, build me up for
what came later), I’d seen yet another specialist, this time in
a national cancer centre. He told me that chemo worked in 5% of
cases and might be worth a try (the previous experts had
dismissed this as only giving a marginal extension of life and
would be lowering my quality of life too). So I did it. All in
2007.
I was also fortunate in having a wife who pulled me out of the
hospice so I could die at home. Meanwhile I’d started the chemo;
had 11 sessions; and did more lifestyle improvements (see
below).
A brief summary is of what I do, based on the best scientific
evidence (check on Google, PubMed): (see supporting evidence by
clicking on the underlined words) and assuming the patient is
sufficiently motivated to survive longer (many are not) to do
this – but if you are new too many of these, then it is probably
best adopting a new one every week or two:
a. Avoid any smoking (and here), both by the patients and those
around them, including e-cigarettes
b. exercise (which pumps the lymph system, the immune system,
around the body): I walk for about 2 hours/day (13,000+
steps/6.5 miles) (also keeps Alzheimer’s disease at bay); and
2-3 times a week I do simple resistance exercises plus 3 bursts
of 20 seconds high intensity interval exercises (HIIT; now on a
stationary cycle, previously sprints) with 2 minutes of slow
between. Run for your life: Exercise protects against cancer (&
here, here, here, here). Check out this, this, this, this, this,
this , this, this, & this, this, this, this. It's never too late
to start exercising, new study shows. It is important also to
enable we cancer patients to reverse ageing effects. Frailty is
another problem that exercise helps with, being itself a source
of early mortality; I use a wobble board to improve my balance.
c. keep your waist below half your height; fat, especially
visceral (waist), enhances inflammation and is a cancer
enhancer. See also here, here, here, here, here, here, here,
here, and here
d. Food effects our genes: so, no alcohol (How alcohol damages
DNA and increases cancer risk), sugar/fast carbs (and here,
here), no diet drinks, little meat, (and here, here, here, here)
processed especially (and here); fish is better. Lots of veggies
works for me. Organic may be best. High-fiber helps (see also
here). I've recently embarked on a "Fasting Mimicking Diet" 5
days/month (fasting in general is thought useful – see here), as
it is reported to reduce ageing/increase immune function (but
probably best not done unless well clear of any evidence of
cancer). See also here, here, here, here, here, here, here.
Avoid processed food, and here. Coffee may be OK. Vegans more
likely than vegetarians to avoid cancer, hypertension, study
says and Right combination of diet and bacteria limits cancer
progression; and here
HTML https://www.sciencedaily.com/releases/2019/05/190522141814.htm
e. Little fruit now, as I keep my sugar intake low - mainly
berries/red-and-black currents
f. Veggies: broccoli, cauliflower, mixed leaves, spinach,
mushrooms, onions, sweet peppers, chilli peppers (as a big salad
at lunch-time). Also see here and here and here
g. Nuts, and here, here, especially walnuts, may help
h. Good oral hygiene - after (not before) breakfast and dinner,
flossing and using a non-fluoride toothpaste. Gum disease is a
major source of inflammation, a cancer stimulant (Periodontal
Disease Linked to Certain Cancer Types, Oral Bacteria Linked
With Pancreatic Cancer; How mouth microbes may worsen colorectal
cancer); and here, here, here; here; here, here, here, here, and
here: Alzheimer’s (and here), bone loss, and cardio-vascular
problems.
i. Good early night's 8-hour sleep every night (& An epidemic of
dream deprivation: Unrecognized health hazard of sleep loss) and
here, here, here, here (but too much isn’t OK)
j. Good, and daily, defecation. I now use a squat stool –
enables me to squat on the toilet, similar to 3rd world
countries, as this enables better elimination (as an appreciable
side-benefit, squatting improves flexibility). The microbiome,
mainly the gut bugs, is a major source of health/illness/immune
system and the bug balance influences this. Research is in its
early stages as to how to improve this, but good throughput
seems to improve things.
k. Filtered water
l. Avoid/do not use such things as air-fresheners, deodorants,
vaporisers, scented candles, here, here, etc; keep home well
aired; maybe use an air-purifier
m. Avoid BPA plastics; beware sunscreens (I've not used them for
years, despite walking for hour/week in the sun, as I've
realised most sunscreens contain cocarcinogens – note: sunscreen
usage has increased in line with skin cancer over the years).
n. Supplements: omega 3 (see here), 2,000IU Vit.D3 daily (and
see here, here, here, here, here, here, but note caution, and
here). Vit.C is found helpful for some cancers. However, avoid
vitamins B6 and B12, especially for lung cancer; and perhaps
Vitamins A, C and E; but note this caution and here. Aspirin or
ibuprofen may help.(see here)
o. Hyperthermia with an infra-red cocoon, and hypothermia:
Immersion or showering in cold water boosts the immune system. I
do this one occasionally.
p. I monitor my body composition daily (a particular problem for
cancer patients is fat- and muscle-wasting – cachexia), my
cancer and kidney with molecular cancer markers every month,
checking in with the consultants if they go above 'normal' for 2
or more months.
q. Do a diary (who, time, date, place) of my medical visits,
questions to ask, answers, advice. I was surprised how often the
medical people lost, even recent, medical data.
r. Join a related forum and/or support group - on line and/or
local.
3. I still monitor health news sites, from which I used to
extract those I considered of most importance for cancer and
posted here on my blog. I recommend you subscribe to one or more
of these to ensure you know of the latest developments.
a. Science Daily Health newsletter
b. Cancer Compass
c. Cancer Network
d. Create a Google Alert for your particular cancer (or anything
for that matter). I have ones for bladder cancer, pancreatic
cancer, hypertension, and kidney disease.
e. The best guide to supplements & nutrition that I know is
Examine
HTML http://examine.com/
f. An authoritative CAM site is National Center for
Complementary and Integrative Health
g. A high quality cancer information website, such as Cancer
Active
h. A good website for alternative treatments is The Truth About
Cancer - though I find it not as authoritative as Cancer Active
HTML https://www.canceractive.com/.
But note Greater Risk of Death in
Cancer Patients Who Choose Alternative Therapies, and Use of
Alternative Medicine for Cancer and Its Impact on Survival,
Alternative medicine kills cancer patients, Outcomes of breast
cancer in patients who use alternative therapies as primary
treatment, Outcome analysis of breast cancer patients who
declined evidence-based treatment, Complementary and alternative
medicine (CAM) use and delays in presentation and diagnosis of
breast cancer patients in public hospitals in Malaysia, Use of
Alternative Medicine for Cancer and Its Impact on Survival,
Complementary Medicine, Refusal of Cancer Therapy, and Survival
Among Patients With Curable Cancers
i. Similarly with regards GreenMedInfo
HTML https://www.greenmedinfo.com/
Bear in mind that there is considerable evidence that cancer is
related to lifestyle, so improving that is important. It helps
the clinical treatments be more effective and reduces the
side-effects. Plus even if a cancer patient goes into remission,
they are always at greater risk of cancer again (and here) than
those who've never had cancer in the first place. Cancer is by
and large a disease of ageing, perhaps due to weakening immune
systems and here, here
Note several things about the information and advice that your
doctor will give you: diagnosis is not an exact science; that
different people respond differently to both the same diagnosis
and the same treatments. Remember, doctors advise, patients
decide (that’s why the doctors get you to sign a form, to say
that it is your decision, not theirs). And that survival times
(the prognosis) are at best averages, based on historical
patients and treatments - whereas hopefully there are constant
improvements which ought to improve the average survival times;
many people live much longer than the average.
There are many cautionary reports to underline my view that the
experts themselves do not always agree, and much of what they
proffer may not be based on research, for example:
I’m alive today, after being told in 2007 that I only had weeks
to live by four consultants.
All doctor's recommended treatments are based on averages –
individual patients will vary greatly in their response, partly
due to their lifestyles but also due to their genetic make-up.
At present these wide variations of response to seemingly
identical treatments for the same diagnosis are
inexplicable/unpredictable.
'Oops... It Wasn't Cancer After All,' Admits The National Cancer
Institute/JAMA
Cancer Patients, Doctors Often Disagree About Prognosis
Teenage cancer victim told he was going to die 16 TIMES by
doctors, is still alive two years later and 14-year-old is
showing signs he is in recovery
Risk factor assessment in high-risk, bacillus
Calmette–Guérin-treated, non-muscle-invasive bladder cancer (the
authors report that two standard predictors were poor)
An example how even experienced experts can differ in their
staging of cancer, and even the same person vary their opinion
over time: Aberrant Histology in NMIBC - What Do We Know and Not
Know
'Three Tyrannies' Threaten Primacy of Science in Oncology
HTML http://www.medpagetoday.com/HematologyOncology/BreastCancer/55292
Medical treatments alone are not enough, good tho' they
undoubtably are: The real benefit of 71 cancer drugs approved in
the last 12 years
Researchers identify health conditions likely to be misdiagnosed
HTML https://www.sciencedaily.com/releases/2019/07/190711105605.htm
"identified three major disease categories -- vascular events,
infections and cancers -- that account for nearly three-fourths
of all serious harms from diagnostic errors."
Medical apartheid: how state medical licensing boards are
silencing good doctors using effective,non-toxic therapies
HTML https://www.quora.com/I-am-newly-diagnosed-with-colon-cancer-How-do-I-move-forward-mentally-and-emotionally
*****************************************************
DIR Previous Page
DIR Next Page